IL135121A - Taste masked pharmaceutical compositions - Google Patents

Taste masked pharmaceutical compositions

Info

Publication number
IL135121A
IL135121A IL13512198A IL13512198A IL135121A IL 135121 A IL135121 A IL 135121A IL 13512198 A IL13512198 A IL 13512198A IL 13512198 A IL13512198 A IL 13512198A IL 135121 A IL135121 A IL 135121A
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
taste masked
masked pharmaceutical
taste
spheronizing
Prior art date
Application number
IL13512198A
Other languages
English (en)
Other versions
IL135121A0 (en
Original Assignee
Scherer Technologies Inc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Inc R P filed Critical Scherer Technologies Inc R P
Publication of IL135121A0 publication Critical patent/IL135121A0/xx
Publication of IL135121A publication Critical patent/IL135121A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL13512198A 1997-10-03 1998-09-30 Taste masked pharmaceutical compositions IL135121A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/942,962 US5904937A (en) 1997-10-03 1997-10-03 Taste masked pharmaceutical compositions
PCT/US1998/020496 WO1999017748A1 (en) 1997-10-03 1998-09-30 Taste masked pharmaceutical compositions

Publications (2)

Publication Number Publication Date
IL135121A0 IL135121A0 (en) 2001-05-20
IL135121A true IL135121A (en) 2005-07-25

Family

ID=25478887

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13512198A IL135121A (en) 1997-10-03 1998-09-30 Taste masked pharmaceutical compositions

Country Status (15)

Country Link
US (1) US5904937A (xx)
EP (1) EP1027038B1 (xx)
JP (2) JP2001518491A (xx)
KR (1) KR100563342B1 (xx)
CN (1) CN1154481C (xx)
AT (1) ATE332126T1 (xx)
AU (1) AU1063799A (xx)
BR (1) BR9812590B1 (xx)
CA (1) CA2303177C (xx)
DE (1) DE69835162T2 (xx)
DK (1) DK1027038T3 (xx)
IL (1) IL135121A (xx)
NO (1) NO20001670L (xx)
PL (1) PL339568A1 (xx)
WO (1) WO1999017748A1 (xx)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU765526B2 (en) 1999-08-17 2003-09-18 Novartis Consumer Health S.A. Rapidly dissolving dosage form and process for making same
DE10003757A1 (de) * 2000-01-28 2001-08-02 Knoll Ag Ibuprofen-Wirkstoffzubereitung
IL134701A0 (en) * 2000-02-23 2001-04-30 J P M E D Ltd Homogeneous solid matrix containing vegetable proteins
IL151475A0 (en) 2000-03-30 2003-04-10 Bristol Myers Squibb Co Beadlets containing stavudine
EP1252886A1 (en) * 2001-04-27 2002-10-30 Universiteit Gent Controlled release pharmaceutical pellet compositions
GB0027357D0 (en) 2000-11-09 2000-12-27 Bradford Particle Design Plc Particle formation methods and their products
US6932861B2 (en) * 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
HUP0303178A3 (en) * 2001-02-05 2008-03-28 R P Scherer Technologies Methods and compositions for reducing the taste of pharmaceutically active agents
BR0205721A (pt) 2001-07-06 2003-09-30 Endo Pharmaceuticals Inc Formulações de oximorfona de liberação controlada
AU2002327418A1 (en) * 2001-08-01 2003-02-17 Bristol-Myers Squibb Company Taste masking composition
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
ES2199061B1 (es) * 2002-06-10 2005-02-16 Laboratorios Vita, S.A. Comprimidos bucodispersables y procedimiento para su obtencion.
US20040037869A1 (en) * 2002-08-16 2004-02-26 Douglas Cleverly Non-animal product containing veterinary formulations
US20040151759A1 (en) * 2002-08-16 2004-08-05 Douglas Cleverly Non-animal product containing veterinary formulations
JP2004107258A (ja) * 2002-09-18 2004-04-08 Ss Pharmaceut Co Ltd 催眠用圧縮成型製剤
ATE534371T1 (de) * 2003-02-06 2011-12-15 Gebro Pharma Gmbh Pharmazeutische zubereitungen und verfahren zu deren herstellung
JP4643899B2 (ja) * 2003-10-20 2011-03-02 エスエス製薬株式会社 イブプロフェン含有錠剤およびその製造方法
KR101288286B1 (ko) * 2005-08-10 2013-07-26 시오노기세이야쿠가부시키가이샤 쓴맛 감소제
US20070036859A1 (en) * 2005-08-11 2007-02-15 Perry Ronald L Sustained release antihistamine and decongestant composition
JP2007131561A (ja) * 2005-11-09 2007-05-31 Ss Pharmaceut Co Ltd 経口固形製剤及びその製造法
US20070286903A1 (en) * 2006-06-13 2007-12-13 Becicka Brian T Composition and method for taste masking
EP2079453A1 (en) * 2006-10-10 2009-07-22 Penwest Pharmaceuticals Co. Robust sustained release formulations
EP1935405A1 (en) * 2006-12-22 2008-06-25 LEK Pharmaceuticals D.D. Orally disintegrating tablets
US10668012B2 (en) * 2008-09-04 2020-06-02 Farnam Companies, Inc. Chewable sustained release formulations
US9925282B2 (en) 2009-01-29 2018-03-27 The General Hospital Corporation Cromolyn derivatives and related methods of imaging and treatment
ES2882797T3 (es) 2009-04-02 2021-12-02 Merck Serono Sa Inhibidores de dihidroorotato deshidrogenasa
WO2011087705A2 (en) * 2009-12-22 2011-07-21 Fmc Corporation Fine particle croscarmellose and uses thereof
CA2814082A1 (en) * 2010-10-12 2012-04-19 Bayer Intellectual Property Gmbh Non-starch based soft chewables
MX350838B (es) 2011-02-11 2017-09-18 Grain Proc Corporation * Composicion de sal.
EP3563849A3 (en) 2012-10-25 2020-02-12 The General Hospital Corporation Combination therapies for the treatment of alzheimer's disease and related disorders
LT3019482T (lt) 2013-02-25 2018-11-26 Aurigene Discovery Technologies Limited Tripakeistieji benzotriazolo dariniai kaip dihidroorotato oksigenazės inhibitoriai
CA2906295C (en) * 2013-03-15 2019-01-22 Argenta Manufacturing Limited Chewable formulation
US10525005B2 (en) 2013-05-23 2020-01-07 The General Hospital Corporation Cromolyn compositions and methods thereof
EP3060205A4 (en) 2013-10-22 2017-06-28 The General Hospital Corporation Cromolyn derivatives and related methods of imaging and treatment
AU2015311674B2 (en) 2014-09-05 2018-03-08 Lupin Inc. Secnidazole for use in the treatment of bacterial vaginosis
CA2988082C (en) * 2015-06-01 2020-09-29 Symbiomix Therapeutics, Llc Novel nitroimidazole formulations and uses thereof
CA3033079A1 (en) 2016-08-31 2018-03-08 The General Hospital Corporation Macrophages/microglia in neuro-inflammation associated with neurodegenerative diseases
US11028054B2 (en) 2017-02-24 2021-06-08 Merck Patent Gmbh 1, 4, 6-trisubstituted-2-alkyl-1H-benzo[d]imidazole derivatives as dihydroorotate oxygenase inhibitors
MA48459B1 (fr) 2017-04-24 2021-09-30 Aurigene Discovery Tech Ltd Méthodes d'utilisation de dérivés de benzotriazole trisubstitués en tant qu'inhibiteurs de dihydroorotate oxygénase
WO2019017995A1 (en) * 2017-07-20 2019-01-24 Aztherapies, Inc. FORMULATIONS OF CROMOLYNE SODIUM POWDER AND IBUPROFEN
EP3508199A1 (en) * 2018-01-05 2019-07-10 Dompé farmaceutici S.p.A. Immediate-release pharmaceutical compositions containing ketoprofen lysine salt
CN113038944A (zh) 2018-07-02 2021-06-25 通用医疗公司 色甘酸钠和α-乳糖的粉末化制剂

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4835187A (en) * 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
NZ234587A (en) * 1989-08-04 1991-11-26 Mcneil Ppc Inc A chewable pharmaceutical tablet of compressed coated granules
CA2039742A1 (en) * 1990-04-23 1991-10-24 Andrew B. Dennis Tablet composition and method for problem pharmaceutical materials
US5075114A (en) * 1990-05-23 1991-12-24 Mcneil-Ppc, Inc. Taste masking and sustained release coatings for pharmaceuticals
US5260072A (en) * 1990-08-30 1993-11-09 Mcneil-Ppc, Inc. Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
CA2068402C (en) * 1991-06-14 1998-09-22 Michael R. Hoy Taste mask coatings for preparation of chewable pharmaceutical tablets
US5225201A (en) * 1991-08-23 1993-07-06 Minnesota Mining And Manufacturing Company Salsalate tablet
BR9206996A (pt) * 1991-12-30 1995-12-05 Fmc Corp Composição adequada para preparar esferóides por esferoidização processo para produzir um material em partículas processo para produzir uma forma de dosagem de sólido esferoidizado em partículas e forma de dosagem sólida
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
EP0713389A4 (en) * 1993-08-13 1997-05-21 Bayer Ag HYDROLYSED GELATINE AS A TASTE IMPROVER IN A CHEWABLE TABLET
ZA945944B (en) * 1993-08-13 1996-02-08 Eurand America Inc Procedure for encapsulating nsaids
ES2082723B1 (es) * 1994-07-20 1996-10-01 Lilly Sa Formulacion farmaceutica de fluoxetina en forma dispersable.
US5637313A (en) * 1994-12-16 1997-06-10 Watson Laboratories, Inc. Chewable dosage forms
US5529783A (en) * 1994-12-19 1996-06-25 Mcneil-Ppc, Inc. Rotor granulation and coating of acetaminophen, pseudoephedrine, chlorpheniramine, and, optionally dextromethorphan
US5686107A (en) * 1995-01-30 1997-11-11 Fmc Corporation Chewable pharmaceutical tablets
US5639475A (en) * 1995-02-03 1997-06-17 Eurand America, Incorporated Effervescent microcapsules

Also Published As

Publication number Publication date
NO20001670L (no) 2000-05-22
DE69835162D1 (de) 2006-08-17
ATE332126T1 (de) 2006-07-15
EP1027038A1 (en) 2000-08-16
EP1027038A4 (en) 2005-02-09
DE69835162T2 (de) 2007-05-31
DK1027038T3 (da) 2006-09-18
AU1063799A (en) 1999-04-27
WO1999017748A1 (en) 1999-04-15
JP2001518491A (ja) 2001-10-16
CA2303177A1 (en) 1999-04-15
BR9812590A (pt) 2000-08-01
IL135121A0 (en) 2001-05-20
NO20001670D0 (no) 2000-03-31
JP2007137902A (ja) 2007-06-07
KR20010024375A (ko) 2001-03-26
CN1273527A (zh) 2000-11-15
PL339568A1 (en) 2000-12-18
BR9812590B1 (pt) 2009-01-13
US5904937A (en) 1999-05-18
EP1027038B1 (en) 2006-07-05
CN1154481C (zh) 2004-06-23
CA2303177C (en) 2005-12-06
KR100563342B1 (ko) 2006-03-22

Similar Documents

Publication Publication Date Title
IL135121A (en) Taste masked pharmaceutical compositions
CA2201967A1 (en) Acetamide derivative having defined particle size
CA2266629A1 (en) Taste-masked microcapsule compositions and methods of manufacture
CA2275717A1 (en) Chitosan-gelatin a microparticles
HK33294A (en) Sustained release pharmaceutical compositions and the preparation of particles for use therein
KR910004180A (ko) 저작성 약제학적 정제를 제조하기 위한 회전과립화 공정 및 맛을 은폐하기 위한 피복공정
NZ502869A (en) Solid pharmaceutical dosage forms of glitazone in a particulate dispersion
CA2119253A1 (en) Medication Vehicles Made of Solid Lipid Particles (Solid Lipid Nanospheres-SLN)
ES8702138A1 (es) Metodo de preparar composiciones farmaceuticas con perfil de desprendimiento controlado bifasico de sustancia activa desde un nucleo de farmaco y desde los poros de un revestimiento de membrana circundante del nucleo.
EP0740581A4 (en) MATERIAL IN PARTICLES
ES2130666T3 (es) Procedimiento de revestimiento de particulas.
IE883810L (en) Sustained release pharmaceutical compositions
HUP9900028A3 (en) Pharmaceutically active quinazoline compounds, their production, use thereof and medicament containing them
AU2038497A (en) Polysaccharide microspheres for the pulmonary delivery of drugs
NZ512683A (en) Taste-masked pharmaceutical particles that are suitable for making chewable tablets
CA2131285A1 (en) Pharmaceutical inhalation compositions
MY117582A (en) Oxacarbazepine film-coated tablets
GB2246514B (en) Sustained release pharmaceutical compositions and the preparation of particles for use therein
ATE239456T1 (de) Pharmazeutische formulierung in form eines trockenen pulvers
SG91270A1 (en) Sustained release formulation
DE69314423T2 (de) Psyllium-Gummiarabicune enthaltendes Arzneimittel
HUP0202088A2 (en) Medicament form for the delivery of collagenase to wounds and process for the preparation thereof
WO2002028424A3 (en) Kyberdrug as autovaccines with immune-regulating effects
WO1997010810A3 (en) Pharmaceutical granules
MX9705834A (es) Nueva composicion farmaceutica que contiene trimebutina y proceso para su preparacion.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees